Nico Frelick | Investor Relations |
Dr. Garo Armen | Chairman and Chief Executive Officer |
Christine Klaskin | Vice President of Finance |
Dr. Steven O'Day | Chief Medical Officer |
Dhan Chand | Scientific Director, Head of Drug Discovery |
David Dye | SNBC |
Matt Phipps | William Blair |
Mayank Mamtani | B. Riley Securities |
Kelly Shi | Jefferies |
Thanks for holding, and welcome everyone to the Agenus Third Quarter 2022 Financial Results Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. I'll now turn the call over to Nico Frelick from Investor Relations.